panitumumab
takeda,amgen
['triplet', 'triplete']
 out in by et al the results of our triplete trial! presented today at #asco2022 by &amp; discussed by intensified chemo backbone with the triplet is not necessary in properly selected ras/braf wt, left-sided pts. patients 
GONO Foundation is a no-profit group of Italian Investigators committed to design & conduct of academic clinical trials in oncology